146 related articles for article (PubMed ID: 4779825)
1. [Effects of the nicotinic ester of 7(2-hydroxyethyl)-theophylline on peripheral arteriopathies in the aged].
Bandinelli G; De Mauro G; Provvedi D; Bellini PG; Rubegni M
Cardiol Prat; 1973; 24(3):275-80. PubMed ID: 4779825
[No Abstract] [Full Text] [Related]
2. [Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Cascio F
Minerva Cardioangiol; 1973 Nov; 21(11):715-31. PubMed ID: 4776567
[No Abstract] [Full Text] [Related]
3. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
4. [Treatment of arterial, peripheral and cerebral circulatory disorders. Clinical results using intravenous infusions of complamine].
Kunert W; Lietz W
Fortschr Med; 1972 Dec; 90(35):1315-7. PubMed ID: 4658025
[No Abstract] [Full Text] [Related]
5. [Chronic peripheral arterial circulation disorders. Experience with the management of chronic peripheral artertial circulation disorders using Complamine].
Mund-Hoym WD
ZFA (Stuttgart); 1978 Nov; 54(33):1726-32. PubMed ID: 568855
[No Abstract] [Full Text] [Related]
6. [Conservative treatment of chronic arterial circulation disorders using a combination of adenosine, theophylline, and sodium nicotinate (ATN)].
Meyer MP
Z Haut Geschlechtskr; 1972 Jul; 47(13):565-9. PubMed ID: 4569523
[No Abstract] [Full Text] [Related]
7. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
Licata G; Pinto A; Parrinello G; Salli L; Indovina I
Clin Ter; 1985 Mar; 112(6):503-13. PubMed ID: 4017475
[No Abstract] [Full Text] [Related]
8. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
De Gregorio G; Scaffidi L; Arcoraci A
Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
[No Abstract] [Full Text] [Related]
9. [On prolonged hemokinetic therapy of occlusive arterial diseases].
Alegría A
Med Klin; 1965 Jul; 60(28):1126-31. PubMed ID: 5835983
[No Abstract] [Full Text] [Related]
10. [Effects of xanthinol nicotinate on the irrigation of the musculature of the limbs and of the skin].
Klüken N; Schmidt H
Angiologia; 1972; 24(6):271-80. PubMed ID: 4641643
[No Abstract] [Full Text] [Related]
11. [Use of a xanthine derivative in peripheral arterial blood flow disorders].
de Weger WP
Med Monatsschr; 1970 May; 24(5):221-5. PubMed ID: 5512478
[No Abstract] [Full Text] [Related]
12. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
Feliciotti F; De Carolis G; Mariotti C; Mingolla F
Ann Ital Chir; 1983; 55(5):493-7. PubMed ID: 6673630
[No Abstract] [Full Text] [Related]
13. [New administration technic for 7,2-hydroxy-3-(N-hydroxyethyl-N-methylamino)-propyl-1,3-dimethylxanthine, pyridine-3-carboxylate (Complamine). Shock-dose arterioclysis].
Rossano C; Testasecca D; Giugliano F; Memé E
Minerva Anestesiol; 1974 Mar; 40(3):124-31. PubMed ID: 4822934
[No Abstract] [Full Text] [Related]
14. [Effects of 3-(methyl-hydroxyethylamino)-2 hydroxypropyltheophylline nicotinate on hemodynamics of the systemic and pulmonary circulation in normal subjects and patients with mitral stenosis].
Filocamo G; Giuffrida G; Basile U; Parrinello A; Bellisario G; Pugliese F
Boll Soc Ital Biol Sper; 1964 Dec; 40(24):Suppl:2121-3. PubMed ID: 5876720
[No Abstract] [Full Text] [Related]
15. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
Elbaz C
Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
[No Abstract] [Full Text] [Related]
16. [Experience with Complamin in peripheral circulation disorders].
Wittenburg H
Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
[No Abstract] [Full Text] [Related]
17. [The action of xanthinol nicotinate on the peripheral circulation of the aged].
Chevat H; Steenhouwer B; Hiltenbrand C; Legrand MF; Graux P
Angeiologie; 1968; 20(2):33-42. PubMed ID: 5682235
[No Abstract] [Full Text] [Related]
18. [Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance].
Nedjabat T; Ebinger H; Birtel FJ
Med Welt; 1976 Aug; 27(34):1585-7. PubMed ID: 948260
[No Abstract] [Full Text] [Related]
19. [Ambulatory treatment of cerebrovascular disorders including encephalographic and ophthalmologic studies].
Leube H; Schwaeppe C
Med Monatsschr; 1970 Aug; 24(8):366-9. PubMed ID: 5515138
[No Abstract] [Full Text] [Related]
20. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
Jovino R; Renda A
Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
[No Abstract] [Full Text] [Related]
[Next] [New Search]
